Szycher M ed. Biocompatible polymers, metals, and composites. Lancaster PA: Technomic, 1983.
6.
Sharma CP, Szycher M eds. Blood compatible materials and devices. Lancaster PA: Technomic, 1991.
7.
Forbes CD, Courtney JMThrombosis and artificial surfaces. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD eds. Haemostasis and thrombosis. Edinburgh : Churchill Livingstone, 1993: 1301-24.
8.
Paul JP, Barbenel JC, Courtney JM, Kenedi RM eds. Progress in bioengineering . Bristol: Adam Hilger, 1989.
9.
Courtney JM, Irvine L., Jones C., Mosa SM, Robertson LM, Srivastava S.Biomaterials in medicine - a bioengineering perspective. Int J Artif Organs1993; 16: 165-71.
10.
Brash JLRole of plasma protein adsorption in the response of blood to foreign surfaces . In: Sharma CP, Szycher M eds. Blood compatible materials and devices. Lancaster PA: Technomic , 1991: 3-24.
11.
Szycher M.Thrombosis, hemostasis, and thrombolysis at prosthetic interfaces . In: Szycher M ed. Biocompatible polymers, metals, and composites. Lancaster PA: Technomic, 1983: 1-83.
12.
Vroman L., Adams AL, Fischer GC, Munoz PCInteraction of high molecular weight kininogen, factor XII and fibrinogen in plasma at interfaces. Blood1980; 55: 156-59.
13.
Evans G., Mustard JFPlatelet-surfaces reaction and thrombosis. Surgery1968; 64: 273-80.
14.
Adams AL, Fischer GC, Vroman L.The complexity of blood at simple interfaces. J Coll Int Sci1978; 64: 468-78.
15.
Lee WH Jr, Krumhaar D., Fonkalsrud EW, Scheide OA, Malorey JV Jr.Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations . Surgery1961; 50: 29-39.
16.
De Leval MR, Hill JD, Mielke CHHaematological aspects of extracorporeal circulation. In: Ionescu MI ed. Techniques in extracorporeal circulation, second edition. London: Butterworths, 1981: 369-89.
17.
Mason RGThe interaction of blood hemostatic elements with artificial surfaces . Prog Hemost Thromb1972; 1: 141-64.
18.
Mason RG, Mohammad SF, Chuang Hyk, Richardson PDThe adhesion of platelets to subendothelium, collagen and artificial surfaces . Semin Thromb Hemost1976; 3: 98-116.
19.
Salzman EW, Lindon J., Brier D., Merrill EWSurface-induced platelet adhesion, aggregation and release. Ann NY Acad Sci1977; 283: 114-27.
20.
Baumgartner HR, Muggli R., Tschopp TB, Turitto VTPlatelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function. Thromb Haemost1976; 35: 124-38.
21.
Fiejen J.Thrombogenesis caused by blood-foreign surface interaction. In: Kenedi RM, Courtney JM, Gaylor JDS, Gilchrist T eds. Artificial organs. London: Macmillan, 1977: 235-47.
22.
Walsh PNPlatelet-coagulant protein interactions. In: Coleman RW, Hirsh J, Marder VJ, Salzman EW eds. Hemostasis and thrombosis: basic principles and clinical practice . Philadelphia: Lippincott, 1982: 404-20.
23.
Needleman SW, Hook JCPlatelets and leukocytes. In: Coleman RW , Hirsh J, Marder VJ, Salzman EW eds. Hemostasis and thrombosis: basic principles and clinical practice . Philadelphia: Lippincott, 1982: 716-25.
24.
Shuman MA, Levine SPRelationship between secretion of platelet factor 4 and thrombin formation during in vitro blood clotting. J Clin Invest1980; 65: 307-13.
25.
Patrono C., Ciabattoni G., Pinca E. et al. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res1980; 17: 317-27.
26.
Phillipa DR , Jennings LK, Prasanna HRCa2+- mediated association of glycoprotein G (thrombin-sensitive protein, thrombospondin) with human blood. J Biol Chem1980; 255: 11629-32.
27.
Waugh DF, Baughman DJThrombin adsorption and possible relations to thrombus formation . J Biomed Mater Res1969; 3: 145-64.
28.
Chuang Hyk, Crowther PE, Mohammad SF, Mason RGInteractions of thrombin and antithrombin III with artificial surfaces . Thromb Res1979; 14: 273-82.
29.
Salzmann EWBlood platelets and extracorporeal circulation . Transfusion1963; 3: 274-77.
30.
Dutton RC, Edmunds LH Jr, Hutchinson JC, Roe BBPlatelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators. J Thorac Cardiovasc Surg1974; 67 : 258-65.
31.
Davies GC, Sobel M., Salzman EWElevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation1980; 61: 808-14.
32.
Addonizio VP Jr, Smith JB, Strauss JF III, Coleman RW, Edmunds LH Jr.Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with a bubble oxygenator . J Thorac Cardiovasc Surg1980 ; 79: 91-96.
33.
McKenna R., Bachman F., Whittaker B., Gibson JR, Weinberger M Jr. The Hemostatis mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation . J Thorac Cardiovasc Surg1975 ; 70: 298-308.
34.
Harker LA, Malpass TW, Branson HE, Hessell EA II, Slichter SJMechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective a-granule release. Blood1980; 56: 824-34.
35.
Edmunds LH Jr, Ellison N., Coleman RW et al. Platelet function during cardiac operation. Comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg1982; 83: 805-12.
36.
Griffin JH, Cochrane CGRecent advances in the understanding of contact activation reactions . Semin Thromb Hemost1979; 5: 254-73.
37.
Irvine L., Sundaram S., Courtney JM, Taggart DP, Wheatley DJ, Lowe Gdo.Monitoring of FXII activity and granulocyte elastase release during cardiopulmonary bypass. Trans Am Soc Artif Intern Organs1991; 37: 369-71.
38.
Sundaram S. , Irvine L., Courtney JM, Taggart DP, Wheatley DJ, Lowe Gdo.Patterns of blood response during cardiopulmonary bypass. Int J Artif Organs1992; 15: 243-48.
39.
Courtney JM, Sundaram S., Forbes CDExtracorporeal circulation: biocompatibility of biomaterials. In: Forbes CD, Cushieri A eds. Management of bleeding disorders in surgical practice. Oxford: Blackwell Scientific , 1993: 236-76.
Courtney JM , Sundaram S., Lamba Nmk, Forbes CDMonitoring of the blood response in blood purification. Artif Organs1993 ; 17 : 260-66.
42.
Brash JL, Uniyal S.Adsorption of albumin and fibrinogen to polyethylene in presence of red cells . Trans Am Soc Artif Intern Organs1976; 22: 253-59.
43.
Brash JLProtein adsorption and blood interactions. In: Szycher M ed. Biocompatible polymers, metals, and composites . Lancaster PA: Technomic1983: 35-52.
44.
Uniyal S., Brash JL, Degterev IAInfluence of red blood cells and their components on protein adsorption . Am Chem Soc Adv Chem1982; 199: 277-92.
45.
Bernstein EF , Blackscher PL Jr, Keller KHFactors influencing erythrocyte destruction in artificial organs. Am J Suirg1967; 14: 126-38.
46.
Bernstein EF , Indeglia RA, Shea MA, Varco RLSublethal damage to the red cell by pumping. Circulation1967 ; 35 (suppl 1) : 226-33.
47.
Altieri CD, Edgington TSSequential receptor cascade for coagulation proteins on monocytes . J Biol Chem1989; 264: 2969-72.
48.
Wright DG, Kauffman JC, Terpstra GK, Graw RG, Deisseroth AB, Gallin JJMobilization and exocytosis of specific (secondary) granules by human neutrophils during adherence to nylon wool infiltration leukapheresis (FL) . Blood1978; 52: 770-82.
49.
Lederman DM , Cumming RD, Petschek HE, Levine PH, Krinsky NIThe effect of temperature on the interaction of platelets and leukocytes with materials exposed to flowing blood. Trans Am Soc Artif Intern Organs1978; 24: 557-60.
50.
Absolom DR, Neumann AW, Zingg W., van Oss CJThermodynamic studies of cellular adhesion. Trans Am Soc Artif Intern Organs1979; 25: 152-56.
51.
Cumming RDImportant factors affecting blood-material interactions. Trans Am Soc Artif Intern Organs1980; 26: 304-308.
52.
Harrison MJ, Emmons PR, Mitchell JRThe effect of white cells on platelet aggregation. Thromb Diathes Haemorrh1966; 16: 105-21.
Saba HI, Herion JC, Walker RI, Roberts HRThe procoagulant activity of granulocytes. Proc Soc Exp Biol Med1973; 142: 614-20.
55.
Kusserow B. , Larrow R., Nichols J.Perfusion- and surface-induced injury in leukocytes. Fed Proc1971; 30: 1516-20.
56.
Bartlett RH, Gazzaniga ABPhysiology and pathophysiology of extracorporeal circulation. In Ionescu M ed. Techniques in extracorporeal circulation, second edition. London: Butterworths, 1981: 1-43.
57.
Pranger RL, Mook PH, Elstrodt JM, Kessler M., Lubbers DW, Wildevuur ChRH. Improved tissue perfusion (PO2 histograms) in extracorporeal circulation using membrane instead of bubble oxygenators . J Thorac Cardiovasc Surg1980; 79: 513-22.
58.
Timmes JJ, Wilson JWMicrocirculatory considerations in extracorporeal oxygenation. NY State J Med1973; 73: 2337-46.
59.
Ratliff NB, Young WG Jr, Hackel DB, Mikat E., Wilson JWPulmonary injury secondary to extracorporeal circulation: an ultrastructural study. J Thorac Cardiovasc Surg1973; 65: 425-32.
60.
Riegel W., Spillner G., Schlosser V., Hörl WHPlasma levels of main granulocyte components during cardiopulmonary bypass . J Thorac Cardiovasc Surg1988; 95: 1014-19.
61.
Herzlinger GAActivation of complement by polymers in contact with blood. In: Szycher M ed. Blood compatible polymers, metals, and composites. Lancaster PA: Technomic, 1983: 89-101.
62.
Chenoweth DEComplement activation produced by biomaterials . Trans Am Soc Artif Intern Organs1986; 32: 226-32.
63.
Kazatchkine MD, Carreno MPActivation of the complement system at the interface between blood and artificial surfaces. Biomaterials1988; 9: 30-35.
64.
Herzlinger GA, Cumming RDRole of complement activation in cell adhesion to polymer blood contact surfaces. Trans Am Soc Artif Intern Organs1980; 26: 165-70.
65.
Wildevuur ChRH , van Oeveren W.Artificial lung: current problems . Life Support Systems1986; 4 (suppl 1): 130-35.
66.
Chenoweth DE , Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JWComplement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins . N Engl J Med1981; 304: 497-503.
67.
Collett B., Alhaq A., Abdullah NB et al. Pathways to complement activation during cardiopulmonary bypass . Br Med J1984; 289: 1251-54.
68.
Kazatchkine MDAlterations in host defence mechanism associated with cardiopulmonary bypass. Life Support Systems1986; 4 (suppl 1) : 144-52.
69.
Blass CR, Jones C., Courtney JMBiomaterials for blood tubing: the application of plasticised polyvinyl chloride. Int J Artif Organs1992; 15: 200-203.
70.
Engbers GH, Feijen J.Current techniques to improve the blood compatibility of biomaterial surfaces . Int J Artif Organs1991 ; 14 : 199-215.
71.
Courtney JM, Yu J., Sundaram S.Immobilisation of macromolecules for obtaining biocompatible surfaces . In: Sleytr UB, Messner P, Pum D, Sára M eds. Immobilised macromolecules: application potentials. London: Springer-Verlag , 1993: 175-93.
72.
Lyman DJ, Knutson K., McNeill B., Shitabani K.The effects of chemical structure and surface properties of synthetic polymers on the coagulation of blood. III. The relation between polymer morphology and protein adsorption. Trans Am Soc Artif Intern Organs1975; 21: 49-53.
73.
Munro MS, Eberhart RC, Maki NJ, Brink BE, Fry WJThromboresistant alkyl derivatized polyurethanes. Am Soc Artif Int Organs J1983; 6: 65-75.
74.
Frautschi JR , Munro MS, Lloyd DR, Eberhart RCAlkyl derivatized cellulose acetate membranes with enhanced albumin affinity. Trans Am Soc Artif Intern Organs1983; 29: 242-44.
75.
Addonizio VP Jr, Maccarak EJ, Nicolaou KC, Edmunds LH Jr.Coleman RWEffects of protacyclin and albumin on platelet loss during an in vitro simulation of extracorporeal circulation. Blood1979; 53: 1033-42.
76.
Larm O., Larsson R., Olsson P.Surface-immobilized heparin. In: Lane DA , Lindahl U eds. Heparin. Chemical and biological properties, clinical applications. London: Edward Arnold, 1989: 597-608.
77.
Rea WJ, Whiteley D., Eberle JWLong-term membrane oxygenation without systemic heparinization. Trans Am Soc Artif Intern Organs1972;18:316-20.
78.
Hagler HK, Powell WM, Eberle JW, Sugg WL, Platt MR, Watson JTFive-day partial bypass using a membrane oxygenator without systemic heparinization . Trans Am Soc Artif Intern Organs1975;21:178-85.
79.
Mottaghy KB , Oedekoven B., Schaich-Lester P., Pöppel K., Küpper W.Application of surfaces with end-point attached heparin to extracorporeal circulation with membrane lungs. Trans Am Soc Artif Intern Organs1989; 35: 146-52.
80.
von Segesser LK, Turina M.Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators. J Thorac Cardiovasc Surg1989; 98: 386-96.
81.
Nilsson L., Storm KE, Thelin S. et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif Organs1990; 14: 46-48.
82.
Palationos GM , Dewanjee MK, Kapadvanjwala M., Novak S., Sfakianakis GN, Kaiser Ga. Cardiopulmonary bypass with a surface heparinized extracorporeal perfusion system. Trans Am Soc Artif Intern Organs1990; 36: M476-79.
83.
Tong SD, Rolfs MR, Hsu LCEvaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits . Trans Am Soc Artif Intern Organs1990; 36: M654-56.
84.
Videm V., Nilsson L., Venge P., Svennevig JLReduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs1991 ; 15 : 90-95.
85.
Chapman D., Charles SAA coat of many lipids - in the clinic. Chem Br1992; 28: 253-56.
86.
Rosenberg RDHeparin-antithrombin system. In: Coleman RW, Hirsh J, Carder VJ, Salzmann EW eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott, 1982: 962-85.
87.
Takahama T. , Kanai F., Iizuka I. et al. Application of a new prostaglandin I2 analogue (APS-306) on cardiopulmonary bypass. Trans Am Soc Artif Intern Organs1984; 30: 44-48.
88.
Rådegran K. , Aren C., Teger-Nilsson A-C.Prostacyclin infusion during extracorporeal circulation for cardiopulmonary bypass. J Thorac Cardiovasc Surg1982; 83: 205-11.
Miyamoto H. , Hirose H., Matsuda H. et al. Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175. Trans Am Soc Artif Intern Organs1985; 31: 508-10.
91.
Heller W., Fuhrer G., Gallimore MJ, Michael H., Hoffmeister H-E.Changes in the kallikrein-kinin system after different dose regimen of aprotinin during cardiopulmonary bypass. In: Abe K , Moriya H, Fujii S eds. Kinins V part B. Advances in experimental medicine and biology. New York: Plenum, 1989: 43-48.
92.
Ohtani M., Matsuda H., Shirakura R. et al. Attenuation of pulmonary leukocyte sequestration during extracorporeal circulation by a new c-AMP phosphodiesterase inhibitor. Trans Am SocArtif Organs1988; 34: 761-64.
93.
Tatsumi E., Matsuda T., Takano H. et al. A synthetic tetrapeptide as a novel platelet-preserving agent during cardiopulmonary bypass. Trans Am Soc Artif Intern Organs1988; 34: 813-16.
94.
Sundaram S. , Coutney JM, Taggart DP et al. Biocompatibility of cardiopulmonary bypass: influence on blood compatibility of device type, mode of blood flow and duration of application. IntJArtif Organs (in press).
95.
Bick RLAlterations of hemostasis associated with surgery, cardiopulmonary bypass surgery, and prosthetic devices. In: Ratnoff OD, Forbes CD eds. Disorders of hemostasis. New York: Grune & Stratton, 1984: 379-409.
96.
Edmunds LH Jr, Stephenson LWCardiopulmonary bypass for open heart surgery . In: Glen WWL, Baue AE, Lindskog BS eds. Thoracic and cardiovascular surgery. New York: Appleton-Century-Crofts, 1982: 1091-106.